Treatment of nail psoriasis with adalimumab: An open label unblinded study: ORIGINAL ARTICLE

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 5, 2010, Pages 530-534

  Rigopoulos, D ^a   Gregoriou, S ^a   Lazaridou, E ^b   Belyayeva, E ^a   Apalla, Z ^b   Makris, M ^a   Katsambas, A ^a   Ioannides, D ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Adalimumab; Anti TNF ; Nail psoriasis; Treatment

Indexed keywords

ADALIMUMAB; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GREECE; HUMAN; INJECTION SITE ERYTHEMA; INJECTION SITE REACTION; NAIL DISEASE; OPEN STUDY; OUTCOME ASSESSMENT; PARAPSORIASIS; PATIENT SATISFACTION; PRIORITY JOURNAL; PSORIASIS SEVERITY INDEX; PSORIATIC ARTHRITIS; QUALITY OF LIFE; QUESTIONNAIRE; TREATMENT OUTCOME; MIDDLE AGED; NAIL DISEASES; PATHOPHYSIOLOGY; PSORIASIS;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; HUMANS; MIDDLE AGED; NAIL DISEASES; PSORIASIS; QUALITY OF LIFE;

EID: 77950851217     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03453.x     Document Type: Article

References (18)

1. Jiaravuthisan MM, Sasseville D, Vender RB, Murphy F, Muhn CY. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 2007 57 : 1 27.
2. Gregoriou S, Kalogeromitros D, Kosionis N, Gkouvi A, Rigopoulos D. Treatment options for nail psoriasis. Exp Rev Dermatol 2008 3 : 339 344.
3. Lamerson C, Stevens G, Sax K. Treatment of nail psoriasis with efalizumab: a preliminary study. Cutis 2008 82 : 217 220.
4. Lawry M. Biological therapy and nail psoriasis. Dermatol Ther 2007 20 : 60 67. (Pubitemid 46568378)
5. Parrish CA, Sobera JO, Robbins CM, Cantrell WC, Desmond RA, Elewski BE. Alefacept in the treatment of psoriatic nail disease: a proof of concept study. J Drugs Dermatol 2006 5 : 339 340.
6. Körver JE, van de Kerkhof PC, Pasch MC. Alefacept treatment of psoriatic nail disease: how severe should nail psoriasis be? J Am Acad Dermatol 2006 54 : 742 743.
7. Cassetty CT, Alexis AF, Shupack JL, Strober BE. Alefacept in the treatment of psoriatic nail disease: a small case series. J Am Acad Dermatol 2005 52 : 1101 1102.
8. Rigopoulos D, Gregoriou S, Stratigos A et al. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study. Br J Dermatol 2008 159 : 453 456. (Pubitemid 352009870)
9. Rich P, Scher RK. Nail psoriasis severity index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol 2003 49 : 206 212. (Pubitemid 36951265)
10. Drake LA, Patrick DL, Fleckman P et al. The impact of onychomycosis on quality of life: development of an international onychomycosis specific questionnaire to measure patient quality of life. J Am Acad Dermatol 1999 41 : 189 196. (Pubitemid 29379702)
11. Sánchez Regaña M, Martín Ezquerra G, Umbert Millet P, Llambí Mateos F. Treatment of nail psoriasis with 8% clobetasol nail lacquer: positive experience in 10 patients. J Eur Acad Dermatol Venereol 2005 19 : 573 577.
12. Rigopoulos D, Gregoriou S, Katsambas A. Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: a double-blind study. Acta Derm Venereol 2007 87 : 167 168. (Pubitemid 46513205)
13. Sánchez Regaña M, Márquez Balbás G, Umbert Millet P. Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment. J Eur Acad Dermatol Venereol 2008 22 : 963 969.
14. Rigopoulos D, Gregoriou S, Daniel CR III. et al. Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment. Dermatology 2009 218 : 338 341.
15. Tosti A, Ricotti C, Romanelli P, Cameli N, Piraccini BM. Evaluation of the efficacy of acitretin therapy for nail psoriasis. Arch Dermatol 2009 145 : 269 271.
16. Luger TA, Barker J, Lambert J et al. Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis J Eur Acad Dermatol Venereol 2009 23 : 896 904.
17. Fernández-Guarino M, Harto A, Sánchez-Ronco M, García-Morales I, Jaén P Pulsed dye laser vs. photodynamic therapy in the treatment of refractory nail psoriasis: a comparative pilot study. J Eur Acad Dermatol Venereol 2009 23 : 891 895.
18. Saurat JH, Stingl G, Dubertret L et al. CHAMPION Study Investigators. Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION). Br J Dermatol 2008 158 : 558 566. (Pubitemid 351239154)